Similar Papers

Paper Title
Journal
Date
Author
Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial
Caroline Schmidt-Lucke ... Jan André Schmidt-Lucke
Thrombosis Research | VOL. 119
Caroline Schmidt-Lucke, et. al.Caroline Schmidt-Lucke ... Jan André Schmidt-Lucke
27 Jan 2006
Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
Christoph Stellbrink ... Walter Sehnert
Circulation | VOL. 109
Christoph Stellbrink, et. al.Christoph Stellbrink ... Walter Sehnert
09 Feb 2004
Trial finds that enoxaparin may be the preferred drug for initiating anticoagulation in atrial fibrillation*1Abstracted from: Stellbrink C, Nixdorff U, Hofmann T, et al. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: The Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial. Circulation 2004; 109: 997-1003.
-
Evidence-based Cardiovascular Medicine | VOL. 8
--
01 Sep 2004
Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial
C Stellbrink ... T Hofmann
ACC Current Journal Review | VOL. 13
C Stellbrink, et. al.C Stellbrink ... T Hofmann
01 Jun 2004
View more papers

More From: Journal of the American College of Cardiology

Paper Title
Journal
Date
Author
Reply: Our Perspective on How Private Equity Platforms Can Accelerate Efforts to Improve Quality and Value.
Victoria L Bartlett ... Rishi K Wadhera
Journal of the American College of Cardiology | VOL. 85
Victoria L Bartlett, et. al.Victoria L Bartlett ... Rishi K Wadhera
28 Jan 2025
Reply: Characteristics of the Population Undergoing Tricuspid Transcatheter Edge-to-Edge Repair in a Real-World Study.
Karl-Philipp Rommel ... Philipp Lurz
Journal of the American College of Cardiology | VOL. 85
Karl-Philipp Rommel, et. al.Karl-Philipp Rommel ... Philipp Lurz
28 Jan 2025
Tricuspid Valve Interventions: A New Era in Cardiovascular Innovation.
Harlan M Krumholz
Journal of the American College of Cardiology | VOL. 85
Harlan M KrumholzHarlan M Krumholz
28 Jan 2025
Our Perspective on How Private Equity Platforms Can Accelerate Efforts to Improve Quality and Value.
Kartik Giri ... Maulik Shah
Journal of the American College of Cardiology | VOL. 85
Kartik Giri, et. al.Kartik Giri ... Maulik Shah
28 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.